SCHRODER INVESTMENT MANAGEMENT GROUP - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 180 filers reported holding NEKTAR THERAPEUTICS in Q2 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2018$316,000
-78.9%
6,562
-53.4%
0.00%
-66.7%
Q1 2018$1,496,000
+78.7%
14,077
+0.4%
0.00%
+200.0%
Q4 2017$837,000
+381.0%
14,016
+90.9%
0.00%
Q3 2017$174,000
+22.5%
7,3410.0%0.00%
Q2 2017$142,000
-58.5%
7,341
-50.0%
0.00%
Q1 2017$342,000
+280.0%
14,682
+100.0%
0.00%
Q4 2016$90,000
-28.6%
7,3410.0%0.00%
Q3 2016$126,000
+21.2%
7,3410.0%0.00%
Q2 2016$104,000
+4.0%
7,3410.0%0.00%
Q1 2016$100,000
-19.4%
7,3410.0%0.00%
Q4 2015$124,000
+55.0%
7,3410.0%0.00%
Q3 2015$80,000
-12.1%
7,3410.0%0.00%
Q2 2015$91,000
+12.3%
7,3410.0%0.00%
Q1 2015$81,000
-28.9%
7,3410.0%0.00%
Q4 2014$114,000
-100.0%
7,341
-70.4%
0.00%
Q3 2014$299,047,000
+217.8%
24,776
+237.5%
0.00%
Q2 2014$94,112,000
+5.8%
7,3410.0%0.00%
Q1 2014$88,973,000
+6.8%
7,3410.0%0.00%
Q4 2013$83,320,000
+8.7%
7,3410.0%0.00%
Q3 2013$76,677,0007,3410.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2016
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
Virtus ETF Advisers LLC 72,018$230,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders